ArticleGenes & diseases2026

GBM-Dx SIGNAL: Blood transcriptomics complementing neuroimaging to differentiate glioblastoma recurrence from treatment effects.

Dan Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.